Sangamo Therapeutics, Inc
SGMOQ- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001001233
No open-market purchases or sales by Sangamo Therapeutics, Inc insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $29.0K in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Sangamo Therapeutics, Inc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 112
- +13 vs. Q4 2025
- Shares held
- 105.4M
- +56.5M (+115.7%) vs. Q4 2025
- Total value
- $26.0M
- +$5.50M (+26.8%) vs. Q4 2025
- New holders
- 29
- 30 more added
- Sold out
- 16
- 16 more reduced
6 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGMOQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $29.0K |
| Q1 2026 | 112 | $26.0M |
| Q4 2025 | 105 | $26.2M |
| Q3 2025 | 112 | $42.1M |
| Q2 2025 | 114 | $39.6M |
| Q1 2025 | 122 | $34.5M |
| Q4 2024 | 128 | $62.9M |
| Q3 2024 | 103 | $48.6M |
| Q2 2024 | 129 | $31.1M |
| Q1 2024 | 131 | $68.2M |
| Q4 2023 | 130 | $47.2M |
| Q3 2023 | 135 | $61.3M |
| Q2 2023 | 152 | $137.4M |
| Q1 2023 | 180 | $197.6M |
| Q4 2022 | 182 | $326.0M |
| Q3 2022 | 197 | $477.2M |
| Q2 2022 | 188 | $371.1M |
| Q1 2022 | 195 | $459.6M |
| Q4 2021 | 193 | $577.0M |
| Q3 2021 | 193 | $679.3M |
| Q2 2021 | 197 | $912.0M |
| Q1 2021 | 203 | $994.7M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Sangamo Therapeutics, Inc; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 1,838,390 | $452.2K | 0.00% | +1,744,406+1,856.1% | Added |
| Jacobs Levy Equity Management, Inc | 2,050,384 | $506.2K | 0.00% | +999,670+95.1% | Added |
| Vanguard Fiduciary Trust Co | 2,310,297 | $570.6K | 0.00% | +2,310,297 | New |
| Charles Schwab Investment Management Inc | 2,352,360 | $580.8K | 0.00% | +639,029+37.3% | Added |
| UBS Group AG | 2,570,992 | $635.0K | 0.00% | +1,546,517+151.0% | Added |
| Renaissance Technologies LLC | 3,836,665 | $947.3K | 0.00% | −4,593,658−54.5% | Reduced |
| BlackRock, Inc. | 4,547,848 | $1.12M | 0.00% | −23,938−0.5% | Reduced |
| Geode Capital Management, LLC | 4,570,862 | $1.13M | 0.00% | +704,836+18.2% | Added |
| Balyasny Asset Management LLC | 5,288,097 | $1.31M | 0.00% | +5,288,097 | New |
| Two Sigma Investments, LP | 6,270,441 | $1.55M | 0.00% | +1,514,446+31.8% | Added |
| Vanguard Capital Management LLC | 12,704,408 | $3.14M | 0.00% | +12,704,408 | New |
| Armistice Capital, LLC | 40,400,067 | $9.97M | 0.33% | +40,400,067 | New |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −4,343,255−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −2,918,127−100.0% | Sold out |
| Wasatch Advisors Inc | 0 | $0 | 0.00% | −1,416,717−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −321,837−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −132,356−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −111,527−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −78,148−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −73,300−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −56,732−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −53,600−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −37,703−100.0% | Sold out |
| Linden Thomas Advisory Services, LLC | 0 | $0 | 0.00% | −19,635−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −1,388−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −1,126−100.0% | Sold out |
| Atlantic Union Bankshares Corp | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Kohmann Bosshard Financial Services, LLC | 0 | $0 | 0.00% | −155−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Oracle Investment Management Inc | – | – | – | – | Not filed |
| Meritage Portfolio Management | – | – | – | – | Not filed |
| Hedges Asset Management LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |